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Abstract
Cannabis sativa is a cheap hallucinating agent used in different parts of the
world from time unknown as a part of various religious as well as social practices.
Cannabis which is a special type of Marijuana can provide temporary relief from
analgesia, body pain, and in some other clinical conditions. But impacts of Cannabis
on reproductive health of males and females are multi-faceted and differentially
fatal. In males, Cannabis can cause changes in testicular morphology, sperm
parameters (in terms of semen quality, sperm morphology, sperm mortality, and
sperm motility), male reproductive hormones and finally causing reduced libido. In
females, Cannabis can reduce female fertility by disrupting hypothalamic release of
gonadotropin releasing hormone (GnRH), leading to reduced estrogen and proges-
terone production and anovulatory menstrual cycles. Current research suggest that
Cannabis may negatively impact on male and female fertility conditions. However,
male sterility considering the Cannabis impact is totally lacking in human as well as
in sub-human primates. However, very limited studies are available on Cannabis
effect on primate female reproduction considering Rhesus monkeys. Hence, further
studies are needed to validate that robust findings in animal models will carry over
into human experience.
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1. Introduction
Cannabis which is a type of marijuana has been used by the people of Indian
subcontinent from time unknown [1]. They not only use this herb as a part of holy
practice but also use it for recreational purposes [2]. Irrespective of sex, this hallu-
cinogenic agent is used by most part of the world particularly by the populations of
South America, India, Bangladesh, and Pakistan from a long time ago [3]. Reports
suggesting the roles of Cannabis causing systemic neuropathy [4], neuronal disabil-
ity [5], impaired fetal development [6], and mal-functioning of male reproductive
system [7–10] are documented. But no reports available are depicting the effects of
marijuana in female reproductive system.
The main causative agent of marijuana/cannabinoids is the endocannabinoid.
This is a neutral lipid and highly conserved molecule throughout evolutionary
history [11]. They are having different derivatives like anandamide [12],
2-arachidonoylglycerol [13] and ∆9-tetrahydrocannabinol (THC) [14]. However,
among all of the fatty acid derivatives of cannabinods or endocannabinoids (eCBs)
the ∆9-tetrahydrocannabinol (THC) has now been established as the most
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important hallucinogenic agent of this molecule [15]. There are literatures
suggesting the role of this ∆9-tetrahydrocannabinol (THC) in regulation of func-
tions of central nervous system and thus regulating the reproductive functions by
affecting/ modulating hypothalamo-pituitary-gonadal axis (HPG-axis) [16] via its
receptor CB1 and CB2 [17]. Now it has been reported that CB1 receptors are
localized mostly in whole vertebrate central nervous system (CNS) and some
peripheral tissues, whereas CB2 receptors are mostly expressed in peripheral tissues
and immune cells, however, they have recently been found also in the CNS [18].
But, with all the advancement in psycho-neuro-endocrine research, till date it is a
matter of debate how THC is going to regulate reproductive system at peripheral
level. Some literatures suggest that, there is a general agreement on the inhibitory
effect exerted by cannabinoids and eCBs on GnRH release [19] Thus, it is affecting
the subsequent FSH and LH release in females and impairing female reproduction
[20].
But, all the above mentioned reported phenomenon are occurring in the central
nervous system and no definitive proof has been reported till date how the
enocannabinoids are affecting peripheral reproductive performances in females
(in terms of gonadal activity, steroidogenesis, receptor expressions, free radical gen-
erations). Thus, aim of the present study was to note the cannabinoid (particularly
endocannabinoid) induced oxidative stress and reproductive impairments in female
mice specifically taking peripheral reproductive organs (ovary) in consideration.
2. Subjects and methods
2.1 Animals and maintenance
In bred adult (12–15 weeks of age), female Parkes strain mice were used for this
study. Mice were maintained under hygienic conditions in a well-ventilated room
with 12-h photoperiod (8 AM to 8 PM, light) with 50  20% relative humidity,
25  2°C temperature and were fed pelleted food (Mona Laboratory Animal Feeds,
Varanasi, India); drinking water was available ad libitum. Five mice in each group
were housed in polypropylene cages (430 mm  270 mm  300 mm), with dry rice
husk as the bedding material. General health condition and body weight of the
animals were monitored regularly during the entire tenure of the experiment. All
experiments were conducted in accordance with principles and procedures
approved by Departmental Research Committee under supervision of Committee
for the Purpose of Control and Supervision of Experiments on Animals, (CPCSEA),
Govt. of India (2007).
Preparations of different doses of Cannabis extracts:
Leaves and flowers of fresh Cannabis plant (100 g cannabis plant) were exten-
sively ground in mortar and pestle with 1 ml autoclaved double distilled water.
From the 1 g/ml paste, 12 mg was weighed and further dissolved in 1 ml autoclaved
double-distilled water to make a stock solution of 12 mg/ml. This solution was
filtered to get a clear solution. Finally, the mice were gavaged Cannabis by means of
a 100 μl micro-pipette using the 12 mg/ml stock.
2.2 Purity assessment of Cannabis preparations
The dry-weight ratio of D9-tetrahydrocannabinol (THC) to cannabidiol (CBD)
and the percent CBD and THC in the cannabis variant found in this region of the world
has been previously reported [21]. The proportion of high THC/CBD chemotype
plants in most accessions assigned to C. sativa was of 25% (Hillig and Mahlberg) [21].
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2.3 Experimental design
Mice were randomly allocated into three groups (groups 1–3). Each group com-
prised of five female mice (n = 5/group). Group 1 was treated with distilled water
(vehicle treated; controls); group 2 was gavaged with 6 mg/100 g body weight/day
aqueous Cannabis preparation; group 3 was gavaged with 12 mg/100 g bodyweight/
day aqueous Cannabis preparation. The mode of oral delivery of extracts were
following the protocol published previously [21]. The tips used for this purpose to
deliver the dose from the micro-pipette had the pointed surface cut to avoid any
injury in the mouth of the mouse. The micro-pipette was used to deliver a small
volume of (20 or 40 μl) dose. The study was continued for 30 days.
2.4 Collection of desired tissues
Mice were weighed before the start of experiment as well as before killing. The
animals were etherized to death and blood was collected from heart. Subsequently
serum was separated and was stored at 20°C until biochemical estimations of total
serum cholesterol and estradiol by ELISA. Both the ovaries and uterine horns were
excised, blotted free of blood and fat tissues and were weighed. The ovary on one
side of the animal was fixed in Bouin’s fluid for histology and immunohistochemical
localization of CB1 receptor. The contra-lateral ovary of each mouse was stored at
20°C until used for enzyme assays (for steroidogenesis, Caspase-3 and free radical
parameters) and western blot analysis of CB1 receptor.
2.5 Antibodies and reagents
All of the chemicals used for the present study were of analytical grade and were
purchased either from Sigma Aldrich (St. Louis, MO, USA) or from Merck (Ger-
many). For western blot analysis, polyclonal primary antibody against CB1 receptor
was purchased from Affinity BioReagents (Rockford, IL, USA, Cat No. RQ4287)
and horseradish peroxidase (HRP)-linked secondary antibody was purchased from
Bangalore Genei Pvt. Ltd. (Bangalore, India). For immunohistochemistry (IHC),
ABC Kit was purchased from ABC staining kit (Universal Elite, Vector Laboratories,
Burlingame, CA). For 3β HSD and 17β HSD assays, pregnenelone was purchased
from Sigma Aldrich (St. Louis, MO, USA).
3. Experimental approaches
3.1 Histological preparations
Ovaries were embedded in paraffin wax and serially sectioned of 6 μm using a
microtome (Leica, Germany). One set of slide was prepared and was further
processed for hematoxylin and eosin staining following the protocol published
elsewhere [22]. The permanent slides were prepared by mounting with DPX
(Distyrene Plasticizer Xylene, SRL, India), after 24 h were observed under micro-
scope (Leitz MPV3 with photo-automat software) and were documented for gen-
eral histology.
3.2 Immunohistochemistry of CB1 receptor
Immunohistochemistry for CB1 receptor was performed following the protocol
published elsewhere [21]. Ovaries of both treated and untreated adult mice were
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paraffin embedded, and 6 mm sections were analyzed by immunohistochemistry,
for CB1receptor to show where, CB1, receptor is localized in mice ovaries and to
have a generalized idea about the receptor expression pattern. For the secondary
antibody and enzyme conjugates, ABC staining was used. Briefly after deparaffi-
nization and hydration, and blocking of endogenous peroxidase with 3% H2O2 in
methanol, sections were incubated with blocking serum for 1 h, followed by incu-
bation with primary antibody (CB1 at a dilution of 1:50) for 1 h at room tempera-
ture. The sections were then washed and incubated with the biotinylated secondary
antibody for 30 min at room temperature, followed by another 30 min with horse
radish avidin-peroxidase conjugated. After washing, sections were incubated with
the chromagen substrate (0.1% 3,3- diaminobenzidine tetrahydrochloride, DAB,
Sigma-Aldrich, USA) in 0.05 M Tris buffer, pH 7.6, and 0.01% H2O2 for 10 min and
then counterstained with Elrich’s hematoxylin. The permanent slides were prepared
by mounting with DPX (Distyrene Plasticizer Xylene, SRL, India), after 24 h were
observed under microscope (Leitz MPV3 with photo-automat software) and were
documented.
3.3 Estimation of total serum cholesterol
The total serum cholesterol was estimated by commercial cholesterol estimation
kit following manufacturer’s protocol (Span Diagnostics, Surat, Gujarat, India).
3β hydroxy steroid dehydrogenase enzyme activity:
3β HSD (EC 1.1.1.145) enzyme was assayed according to the protocol of
Shivanandappa and Venkatesh [23] using ovarian homogenate. Ten percent tissue
homogenate was prepared in 0.1 M Tris-Cl buffer (pH 7.8). The homogenate was
centrifuged at 12,000  g at 4°C and the supernatant was used as the source of
enzyme. The enzyme was assayed in 0.1 M Tris-Cl buffer (pH 7.8) containing
500 mM NAD, 100 mM pregnenolone as substrate and enzyme (50 ml) in a total
volume of 3.0 ml and incubated at 37°C for 1 h. The reaction was stopped by the
addition of 2.0 ml of phthalate buffer (pH 3.0) and the absorbance was noted at
490 nm. The enzyme activity was calculated from the standard curve of NADH and
expressed as nmol NADH formed/h/mg protein.
3.4 17β hydroxy steroid dehydorgenase enzyme activity
17β HSD (EC 1.1.1.62) activity was measured by following the protocol of
Jarabek et al. [24]. In brief, 10% homogenate of the ovarian tissues were prepared in
normal Phosphate Buffered Saline (PBS; pH 7.4) and 250 μl of the supernatant was
mixed with 250 μl of 440 μM sodium pyrophosphate buffer (pH 10.2), 10 μl ethanol
containing 0.3 μM estradiol (Sigma, St. Louis, USA) and 240 μl of 25 mg% BSA.
Enzyme activity was measured after addition of 50 μl of 0.5 μMNAD to the mixture
in a spectrophotometer at 340 nm against a blank (without NAD). One unit of
enzyme activity was the amount causing a change in absorbance of 0.001/min at
340 nm.
3.5 Evaluation of SOD activity in ovary
Superoxide dismutase (SOD; EC 1.15.1.1) activity was assayed following the
method of Das et al. [25]. Just after sacrifice, 10% homogenates of all ovarian tissues
from group 1 and set-III mice were prepared in 150 mM phosphate buffered
saline (PBS, pH 7.4) and centrifuged for 30 min at 12,000 g at 4°C. The
supernatant was again centrifuged for 60 min at 12,000 g at 4°C and then
processed for enzymatic activity based on a modified spectrophotometric method
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using nitrite formation by superoxide radicals. A 0.5 ml of homogenate was added
to 1.4 ml of reaction mixture comprised of 50 mM phosphate buffer (pH 7.4),
20 mM L-methionine, 1% (v/v) Triton X- 100, 10 mM hydroxylamine hydrochlo-
ride, 50 mM ethylene diamine tetraacetic acid (EDTA) followed by a brief pre-
incubation at 37°C for 5 min. Next, 0.8 ml of riboflavin was added to all samples
along with a control containing buffer instead of sample and then exposed to two
20 W fluorescent lamps fitted parallel to each other in an aluminum foil coated
wooden box. After 10 min of exposure, 1 ml of Greiss reagent was added and
absorbance of the color formed was measured at 543 nm. One unit of enzyme
activity is defined as the amount of SOD inhibiting 50% of nitrite formation under
assay conditions.
3.6 Estimation of catalase activity in ovary
Catalase (CAT; EC 1.11.1.6) activity was measured following the procedure of
Sinha [26]. This method is based on the fact that dichromate in acetic acid is
reduced to chromic acetate when heated in the presence of H2O2with the formation
of perchromic acid as an unstable intermediate. The chromic acetate thus produced
is measured calorimetrically. The catalase preparation is allowed to split H2O2 for
different periods of time. The reaction is stopped at a particular time by the addition
of dichromate/acetic acid mixture and the remaining H2O2 is determined by mea-
suring chromic acetate calorimetrically after heating the reaction mixture. There is
production of green color at the end of the process. Immediately after sacrifice, 20%
homogenate of ovarian tissues from groups 1 to 3 were prepared in PBS (10 mM;
pH = 7.0) and then centrifuged at 12,000 g for 20 min at 4°C. Supernatant was
taken for enzyme estimation. About 5 ml of PBS was added to 4 ml of H2O2
(200 mM) and then 1 ml of enzyme extract was added. After 1 min 1 ml of this
solution was taken in a tube and 2 ml of K2Cr2O7 (5%) solution was added. Then, it
was boiled for 10 min and absorbance was measured at 570 nm. The activity of CAT
was expressed as amount of H2O2 degraded per minute.
3.7 Estimation of lipid peroxidation (LPO) assay by thiobarbituric acid reactive
substances (TBARS) level estimation in ovary
After sacrifice of the mice of all the groups, the ovarian tissues were dissected
out on a sterile watch glass placed in ice box, cleaned from adherent tissues and
processed immediately for estimation of lipid peroxidation. Ovarian tissues of
groups 1–3 experimental mice were weighed and homogenized in a tenfold excess
of 20 mM Tris-HCl buffer (pH 7.4) and the 10% homogenates were centrifuged for
15 min at 3000  g at 4°C. The supernatant was subjected to thiobarbituric acid
(TBA) assay by mixing with 8.1% sodium dodecyl sulfate (SDS), 20% acetic acid,
0.8% TBA and then digested it for 1 h at 95°C. The reaction mixture was immedi-
ately cooled in running water, vigorously shaken with 2.5 ml of n-butanol and
pyridine reagent (15:1) and centrifuged for 10 min at 1500 g (Ohkawa et al. ) [27].
The absorbance of the upper phase was measured at 534 nm. Total thiobarbituric
acid reactive substances (TBARS) were expressed as malondialdehyde (MDA;
nmol/g tissue weight) taking 1,1,1,1-tetraethoxy propane (TEP) as standard. The
standard curve was calibrated using 10 nM TEP.
3.8 Glutathione peroxidase (GPx) estimation in ovary
Glutathione peroxidase (GPx; EC 1.11.1.9) activity was assayed as described by
Mantha et al. [28]. The reaction mixture (1 ml) contained 50 μl sample, 398 μl of
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50 mM phosphate buffer (pH 7.0), 2 μl of 1 mM EDTA, 10 μl of 1 mM sodium azide,
500 μl of 0.5 mM NADPH, 40 μl of 0.2 mM GSH, and 1 U glutathione reductase.
The reaction mixture was allowed to equilibrate for 1 min at room temperature.
After this, the reaction was initiated by addition of 100 mMH2O2. The absorbance
measured kinetically at 340 nm for 3 min. The GPx activity was expressed as nmol
of oxidized NADPH oxidized to NADP+ per min per mg of protein using an
extinction coefficient (6.22 mM1 cm1) for NADPH.
3.9 Caspase 3 activity assay
Thecal cell suspension was prepared following the protocol of Sharma et al.,
[29]. In brief, thecal cell suspensions from all the groups were prepared by mincing
the entire ovary in ice-cold 1  PBS, at 4°C. After washing, cell pellets were
collected by centrifugation at 500 g for 10 min at 4°C and the supernatant was
gently removed. Cell pellets were lysed by the addition of 50 ml of cold lysis buffer
(5 mM Tris, 20 mM EDTA, 0.5% Triton-X 100, pH 6.0) per 2  6 106 cells and
incubated on ice for 10 min. Lysates were centrifuged at 10, 000 g for 1 min at 4°C,
and the supernatant was transferred to a fresh tube and processed for caspase-3 (EC
3.4.22.xx) activity using a caspase-3 colorimetric assay kit, according to manufac-
turer’s instructions (R&D Systems, Inc. MN). Each enzymatic reaction, carried out
in a 96-well flat bottommicroplate, required 50 ml cell lysate, 50 ml reaction buffer,
and 5 ml caspase-3 colorimetric substrate (DEVD-pNA). The plate was incubated at
37°C for 2 h with a substrate blank and sample blank. At the end of the incubation
period, the absorbance of enzymatically released chromophore p-nitroanilide
(pNA) was read at 405 nm in a microplate reader (Tecan, Spectra II-micro-ELISA
plate reader, Austria). Caspase-3 activity was determined by comparing the absor-
bance or optical density (OD) of pNA from apoptotic samples with the untreated
control and expressed as fold increase in OD405/10
6 cells per ml [29].
3.10 Serum level of estradiol
Estradiol was assayed using ELISA kit (Biotron Diagnostics Inc., USA) according
to manufacturer’s protocol. The coefficient of intra- and inter-assay variation was
less than 4.1 and 6.4%, respectively. The analytical sensitivity was 10 pg/ml.
3.11 Western blot analysis of Cannabinoid receptor 1 (CB1) analysis
The ovarian tissue protein pooled from six mice was extracted as described
earlier [30]. For western blot analysis, 10% ovarian homogenate was prepared.
Equal amounts of proteins (50 mg) determined by Bradford’s method were loaded
on SDS PAGE (10%) for electrophoresis. Thereafter, proteins were transferred
electrophoretically to nitrocellulose membrane (NC; Sigma-Aldrich, USA) over-
night at 4o.C NC was then blocked for 60 min with Tris-buffered saline (TBS; Tris
50 mM, pH 7.6) and then incubated with primary antiserum (CB1 at a dilution of
1:250) for 1 h. Then, membranes were washed for 10 min each (three washes) in
TBS-Tween 20. Then, NC membrane was incubated with secondary conjugated
with serum immunoglobulin (1:500) for 30 min and then washed in TBS for 10 min
(three times). Signals were detected using an ECL kit (Bio-Rad, Hercules, CA). Blot
for each protein was repeated for three times. The densitometry analysis of blots
was performed by scanning and quantifying the bands for density value by using
computer-assisted image analysis (Image J 1,38X, NIH). The densitometry data
were presented as the mean of the integrated density value  SEM. A pre-stained
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multicolor broad range marker (Spectra TM multicolor broad range marker; 10 to
260 kDa x SM-1841; Fermentas, MD, USA) was also run along with sample proteins
to clarify the position of band obtained as published elsewhere previously to detect
the specificity of the bands [30].
3.12 Statistical analyses
The data were analyzed on Microsoft Office Excel worksheet followed by one
way ANOVA. All data are expressed as mean  SEM. The data were considered
significant if P < 0.05. Further, to note the level of significance between the
experimental groups Duncan’s multiple range post-hoc test was applied. All of the
estimations were done in single lot using replicates and were repeated thrice. Ana-
lyses were done using Statistical Package for Social Sciences software version 16 for
windows (SPSS, 16.0, IBM, Chicago, IL, USA) and in accordance to Brunning and
Knitz [31].
4. Results
4.1 Histomorphology of ovary
The ovarian sections of both 6 mg/100 g of body weight and 12 mg/100 g of
body weight showed degeneration of ovarian micro-architecture in comparison to
control. There was absence of corpora-lutea in the ovaries of Cannabis treated mice.
The ovaries of 12 mg/100 g of body weight showed highest number of degenerating
follicles.
4.2 Immunohistochemistry of CB1 receptor in ovary
CB1 receptors protein was demonstrated immunohistochemically in the ovaries
of the control and Cannabis treated groups of mice. The immunoreactivity of CB1
receptors was mainly observed in the granulose cells of secondary follicles in the
control group. There was a dose-dependent increase in the expression of the CB1
receptor in the ovarian sections. Intense staining was also observed in the
degenerating follicles and oocyte (group 3). However, negative control did not
show any immunostaining.
4.3 Body weight
We noted a significant (P < 0.05) decrease in body weight in a dose dependent
manner following Cannabis treatment in comparison to control. However, the dif-
ferences of body weight between two experimental groups were not significant
(P > 0.05).
4.4 Ovarian weight
We recorded the ovarian weight upon Cannabis treatment. It was observed that
upon Cannabis treatment the ovarian weight was significantly low (P < 0.01) in
dose dependent manner as compared to control. Among two experimental groups,
the difference in weight was also statistically significant (P < 0.05).
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4.5 Uterine weight
We recorded the same result in uterine weight also where Cannabis treatment
profoundly (P < 0.01) decreased uterine weight as compared to control. However,
the difference in uterine weight between two experimental groups was not signifi-
cant (P > 0.05).
4.6 Total serum cholesterol
Serum cholesterol also showed significant dose dependent decrease (P < 0.01)
in serum cholesterol level upon Cannabis treatment being lowest in 12 mg/100 g of
body weight group as compared to control. However, the difference between two
experimental groups was statistically non-significant (P > 0.05).
4.7 3β HSD enzyme activity in ovary
Significant decrease in 3β HSD enzyme activity (P < 0.01) was noted in a dose
dependent manner in Cannabis treated ovaries as compared to control. However,
the difference between two experimental groups was statistically non-significant
(P > 0.05).
4.8 17β HSD enzyme activity in ovary
Significant decrease (P < 0.01) in 17β HSD enzyme activity was noted in Can-
nabis treated ovaries in comparison to control. The difference in decreased activity
between two experimental groups was also statistically significant (P < 0.05).
4.9 SOD activity in ovary
Significant increase in SOD activity was noted in Cannabis treated groups in
dose dependent manner being significantly high (P < 0.01) in both the groups of
6 mg/100 g of body weight and 12 mg/100 g of body weight as compared to control.
The level was highest in the latter group in comparison to 6 mg/100 g of body
weight (P < 0.05).
4.10 Catalase activity in ovary
Significant increase in catalase activity was noted in Cannabis treated groups in
dose-dependent manner (P < 0.01) as compared to control. But, among the treated
groups the level was not significant (P > 0.05).
4.11 Malondialdehyde level in ovary
Significant decrease in ovarian malondialdehyde levels were noted in a dose
dependent manner following Cannabis treatment being lowest in 12 mg/100 g of
body weight dose (P < 0.01). The level in the 6 mg/100 g of body weight dose was
intermediate with significantly lower level (P < 0.05) than control. Among the
treated groups, group 3 showed least level of MDA activity (P < 0.05).
4.12 GPx level in ovary
Glutathione peroxide (GPx) level was found to be significantly high (P < 0.01)
in both the treatment groups when compared to control. Among 6 mg/100 g body
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weight and 12 mg/100 g body weight groups, the latter showed significantly high
level (P < 0.01).
4.13 Caspase 3 activities in ovarian thecal cells
Caspase 3 activity was assayed in the ovarian thecal cells upon cannabis treat-
ment. We noted a significant increase of caspase 3 in the thecal cells in dose
dependent manner being highest in 12 mg/100 g of body weight dose (P < 0.01) in
comparison to control. Further, among the treated groups, group 3 presented the
highest level of caspase 3 activity (P < 0.01).
4.14 Serum level of estradiol
Serum level of estradiol was found to be significantly low (P < 0.05) in 6 mg/
100 g of body weight dose; however, the level was further significantly low (P
< 0.01) in 12 mg/100 g of body weight dose as compared to control which was
recorded to be significantly low among the treated groups (P < 0.05).
4.15 Western Blot analysis of CB1 receptor in ovaries of mice
We noted a significant increase (P < 0.05) in Cannabinoid receptor type 1 (CB1)
in 6 mg/100 g of body weight treatment group. The level was further significantly
high (P < 0.01) in 12 mg/100 g of body weight group as compared to control group.
Further, the level of expression was highest in group 3 (P < 0.05) as compared
among the treated groups.
5. Discussions
The present study was confined on the role of chronic Cannabis induced oxida-
tive stress and reproductive impairment in female mice. In the recent years, there
are several literatures available depicting the role of Cannabis in neuro-
degeneration [32], neuro-myopathy [33] and different other neurological disorders
[34]. But, till date there are no data or reports are available depicting the role of
Cannabis treatment in regulating/modulating the female reproduction, however, it
had been predicted from prolonged time that Cannabis is potent enough to interfere
in reproduction in males [35] and females.
Our study, in relation to the dose dependent effect of Cannabis treatment in the
female reproduction is the preliminary and elaborated study depicting the deleteri-
ous and detrimental effects of Cannabis in female reproduction. Our study is
divided into two different parts addressing the role of Cannabis in reproductive
impairments in female mice due to oxidative stress and loss in the functions of
steroidogenesis.
We noted a significant decrease in body weight, ovarian and uterine weight
upon Cannabis treatment suggesting the first clue in reproductive impairment upon
Cannabis treatment. The results were further supported by degeneration in ovarian
histomormhology and increase in expressions of CB1 receptors in ovaries of differ-
ent treatment groups. Cumulatively, the histological and immunohistochemical
data suggest a dose dependent impairment in ovarian as well as reproductive func-
tions which are in agreement with previous reports in where Cannabis causes
reproductive impairment in males [36]. We have also studied the different aspects
of free radical as well as reproductive enzyme activities (3β HSD and 17β HSD). The
SOD, catalase and GPx levels were significantly high in ovary tissues where as MDA
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level was significantly low. The increased results of free radical scavenging enzyme
activities suggest the reproductive impairment in mice is may be due to high
generation of free radicals and also due to different physiological malfunctions
which are yet to be traced out [37–40].
Further, significant decrease in total serum cholesterol levels, estradiol levels in
circulation, 3βHSD and 17βHSD enzyme activities in ovarian tissues upon Cannabis
treatment were noted. Thus, we may suggest that upon Cannabis treatment repro-
duction in females was impaired by Cannabis treatment by generation of free
radicals in female reproductive tissues. The results were also discussed in light of
apoptosis in thecal cells by Caspase 3 activity assays and it was found to be signifi-
cantly high in different doses of Cannabis treatments. To delineate the possible
molecular mechanism of Cannabis function in ovary, we checked the CB1 receptor
expression in ovarian tissues and we also found that the CB1 receptor expressions
were significantly high in both the 6 mg/ 100 g of body weight and 12 mg/100 g of
body weight groups which are in agreement with the reports published earlier
[41–43].
Thus, we may suggest that Cannabis treatments were not only impairing the
reproduction in females but also chronic duration of doses is responsible for high
fecundity in terms of reproductive malfunctions.
6. Conclusion
This study, for the first time showed the effect of administration of Cannabis, in
controlling the reproductive process in female mice. It also showed the interrelation
between the exogenous administrations of Cannabis, the possible mechanism that
was not dealt by earlier workers showing anti-fertility effect of cannabis for females
in particular.
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